The Dallas Cowboys suffered one of the franchise's more embarrassing losses in recent memory on Thursday night at AT&T Stadium, falling to the Tampa Bay Buccaneers in a 24-16 defeat. Led by undrafted ...

The litany of bad losses suffered by the Dallas Cowboys here in the first two years of the Brian Schottenheimer coaching tenure is getting uncomfortably long, but what happened Thursday against the ...

The Dallas Cowboys are doing that thing again, and the 2026 version of it has been tough to watch at times. Despite sky-high expectations heading into the season, a loaded offense, and a defense with ...

‘He’s a Puppet,’ ‘Jerry Jones Is Geppetto’ — NFL Legend Slams Cowboys HC Brian Schottenheimer for Publicly Singling Out George Pickens The Dallas Cowboys are off to a disappointing 2-4 start to their ...

Trying to find any sort of silver lining after such an embarrassing performance against the Tampa Bay Buccaneers can be an exercise in frustration. Continued defensive woes, a sputtering offense, even ...

A winless opponent and playing at home felt like the perfect mix for the Cowboys to get over the .500 mark. Somehow, though, it proved to be a Texas two-step for a disaster. Dallas suffered a 24-16 ...

The New York Yankees are one loss away from elimination after losing 5-2 in Game 2 of the ALDS against the Tampa Bay Rays at Tropicana Field on Monday. New York lost the first game of the series 1-0 ...

For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose? Now it is changing to: What kind of weight are they losing? Rapid weight loss can ...

Eli Lilly said its experimental combination regimen resulted in greater weight loss than a high dose of its top-selling drug, tirzepatide, alone in a mid-stage trial on patients with obesity and Type ...

A next-generation weight-loss drug from Eli Lilly LLY-0.67%decrease; down pointing triangle, when combined with Zepbound, helped people lose substantially more weight than Zepbound alone, according to ...

Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...